To uncover how YTHDC2 suppresses bladder cancer, we conducted RNA sequencing, proteomics, and m6A methylated RNA immunoprecipitation (MeRIP) sequencing to identify the potential downstream effectors. This evidence concerns the gene YTHDC2 and urinary bladder cancer.